Carlsmed, Inc. (CARL) stock
Close on Oct 30, 2026Market cap $408.18MP/E –Yield –
Earnings
Carlsmed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Carlsmed's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026after the close | $18.90M | +56.2% | -$0.39 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026after the close | $16.10M | – | -$0.32 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026after the close | $15.20M | – | -$0.32 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $13.10M | – | -$0.40 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 28, 2025after the close | $12.10M | – | -$1.47 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Carlsmed's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | FY2026 | $74.00M – $78.00M | $72.00M – $77.00M | Raised | Aug 5, 2026 |
| Revenue | FY2026 | $70.00M – $75.00M | – | New | Feb 25, 2026 |
Guidance history
Every forecast Carlsmed put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 5, 2026 | Revenue | FY2026 | $74.00M – $78.00M | Raised |
| May 5, 2026 | Revenue | FY2026 | $72.00M – $77.00M | New |
| Feb 25, 2026 | Revenue | FY2026 | $70.00M – $75.00M | New |
| Nov 6, 2025 | Revenue | FY2025 | $49.00M – $50.00M | New |
| Aug 28, 2025 | Revenue | FY2025 | $45.50M – $47.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Carlsmed filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results